WinstonWınston
Encision logo

Encision

ECIA
24
Medical - Instruments & Supplies · Healthcare
Price
$0.05
+0.01 (+35.33%)
Market Cap
$562,747
Winston Score
24
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+28.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 11.6M (2022) → 14.9M (2026)

Encision Inc. makes surgical tools used in operating rooms. The company specializes in electrosurgical instruments — devices that use electrical energy to cut tissue and stop bleeding during surgery. Its main customers are hospitals and surgical centers, and its flagship technology is a safety system called AEM (Active Electrode Monitoring) that reduces the risk of accidental burns to patients during minimally invasive surgery.

Encision sells its products through a combination of hardware sales and a recurring blade and instrument business, meaning hospitals keep buying disposable tools after the initial purchase. The company operates primarily in the United States and is a small player in the broader surgical instruments market, competing against much larger companies like Medtronic and Stryker. Its AEM safety technology is a key differentiator, but the company's negative operating margin signals it is spending more than it earns, and sustaining profitability while competing against well-funded rivals remains the central challenge.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+88.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$758,960/ year

Rising (+28% vs prior year)

13.1% of revenue

Below sector average (18%)

Investing heavily in future products and technology

Insider Activity

63.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~4 months

$257,433 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Encision has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
56.2%
Premium pricing power — 56.2% gross margin
Operating Margin
-1.3%
Losing money on operations — -1.3%
ROCE
-0.9%
Weak — -0.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-7.9%
Shrinking sales (-7.9% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-4.7%
Burning cash (-4.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.37
Conservative — low debt load (0.37)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial